Correlation Between Eterna Therapeutics and Tourmaline Bio

Can any of the company-specific risk be diversified away by investing in both Eterna Therapeutics and Tourmaline Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eterna Therapeutics and Tourmaline Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eterna Therapeutics and Tourmaline Bio, you can compare the effects of market volatilities on Eterna Therapeutics and Tourmaline Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eterna Therapeutics with a short position of Tourmaline Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eterna Therapeutics and Tourmaline Bio.

Diversification Opportunities for Eterna Therapeutics and Tourmaline Bio

-0.34

Correlation Coefficient

Eterna Therapeutics  Tourmaline Bio

Very good diversification

The 3 months correlation between Eterna and Tourmaline is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Eterna Therapeutics and Tourmaline Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tourmaline Bio and Eterna Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eterna Therapeutics are associated (or correlated) with Tourmaline Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tourmaline Bio has no effect on the direction of Eterna Therapeutics i.e., Eterna Therapeutics and Tourmaline Bio go up and down completely randomly.

Pair Corralation between Eterna Therapeutics and Tourmaline Bio

Given the investment horizon of 90 days Eterna Therapeutics is expected to under-perform the Tourmaline Bio. In addition to that, Eterna Therapeutics is 1.26 times more volatile than Tourmaline Bio. It trades about -0.07 of its total potential returns per unit of risk. Tourmaline Bio is currently generating about 0.06 per unit of volatility. If you would invest  1,364  in Tourmaline Bio on September 12, 2024 and sell it today you would earn a total of  1,136  from holding Tourmaline Bio or generate 83.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Eterna Therapeutics  vs.  Tourmaline Bio

Eterna Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eterna Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Tourmaline Bio

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Tourmaline Bio are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite weak primary indicators, Tourmaline Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eterna Therapeutics and Tourmaline Bio

The main advantage of trading using opposite Eterna Therapeutics and Tourmaline Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eterna Therapeutics position performs unexpectedly, Tourmaline Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tourmaline Bio will offset losses from the drop in Tourmaline Bio's long position.

The idea behind Eterna Therapeutics and Tourmaline Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.